ICON Joins Groundbreaking Genome Initiative

Brendan Buckley, chief medical officer for ICON.

By Julia Brodsky, Editorial Assistant
April / May 2016

ICON plc was recently selected by Genomics England to support their “100,000 Genomes” project, the world’s largest genome sequencing project for cancer and rare diseases, which could revolutionize the diagnosis and treatment of various cancers and rare diseases.

Announced by British Prime Minister David Cameron in 2012, the project will compile 100,000 whole genomes from 70,000 individual National Health Service (N.H.S.) patients and their families. This data, once sequenced and de-identified, will become available to approved researchers who will assist in developing tools for diagnosis and treatment based on individual patients’ genetic characteristics. It is currently the largest project of its kind worldwide.

ICON, a company that offers drug development solutions to the medical industries, is headquartered in Dublin and will use its substantial data management capabilities to support and organize the clinical data collected from the 70,000 patients and their families.

“Our partnership with Genomics England demonstrates our commitment to partnering with industry and government organizations in new and innovative ways to improve patient care by accelerating the development of targeted and personalized medicines that tackle complex diseases,” said Professor Brendan Buckley, ICON’s Chief Medical Officer (left).

Managing Director for the 100,000 Genomes project, James Peach, was equally enthusiastic about the partnership. “We are delighted to be partnering with ICON,” he said.

“Their renowned expertise in data management will be fundamental in driving scientific research and accelerating the return of results for N.H.S. patients.” ♦

Leave a Reply




Share



More Articles

Dr. Kevin Tracey in the lab at Northwell Health System's Feinstein Institute for Medical Research in Manhasset, NY.
Dr. Kevin J. Tracey: Inventing the Future of Medicine

Dr. Kevin J. Tracey, president & CEO of the Feinstein Institutes, is a trailblazer in the neuroscience of immunity,...

More

Dr. Lisa Connolly.
Queen’s University
Takes on Fertility Issues

Queen’s University Belfast has been awarded 6.1 million euros, in collaboration with 11 other global partner...

More

NUI Galway Collaborate on Global Antimicrobial Resistant Bacteria Study

NUI Galway participates in major international study showing sewage can reveal levels of antimicrobial resistance...

More

Irish Nurses Strike for Fair Pay

Ireland’s nurses went on strike on January 30 in a dispute over pay and staff shortages. There were three separate...

More